Review



large molecule rage inhibitor ttp4000  (TransTech Pharma)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    TransTech Pharma large molecule rage inhibitor ttp4000
    Proposed schematic of the relationship between soluble <t>RAGE</t> and neutrophilic inflammation in chronic airways disease. Epithelial damage (1) caused by environmental insults induces the release of DAMPs (e.g. the RAGE ligands HMGB1, SAA) (2). DAMPs induce recruitment and activation of neutrophils in the airway space (3). DAMPs might also act in an autocrine manner to activate RAGE on airway epithelial cells (4), leading to the generation of further DAMPs (5), thus amplifying the inflammatory response. Activated neutrophils up-regulate the RAGE ligand Mac-1/CD11b on their surface and might therefore interact with airway epithelial cells via a RAGE-dependent mechanism (6). Neutrophil-derived proteases degrade soluble RAGE (7), the <t>endogenous</t> <t>inhibitor</t> of RAGE signalling (8), leading to unopposed neutrophil recruitment, activation and persistence in the airways and a failure to resolve the inflammatory response.
    Large Molecule Rage Inhibitor Ttp4000, supplied by TransTech Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/large molecule rage inhibitor ttp4000/product/TransTech Pharma
    Average 90 stars, based on 1 article reviews
    large molecule rage inhibitor ttp4000 - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "RAGE: a new frontier in chronic airways disease"

    Article Title: RAGE: a new frontier in chronic airways disease

    Journal: British Journal of Pharmacology

    doi: 10.1111/j.1476-5381.2012.01984.x

    Proposed schematic of the relationship between soluble RAGE and neutrophilic inflammation in chronic airways disease. Epithelial damage (1) caused by environmental insults induces the release of DAMPs (e.g. the RAGE ligands HMGB1, SAA) (2). DAMPs induce recruitment and activation of neutrophils in the airway space (3). DAMPs might also act in an autocrine manner to activate RAGE on airway epithelial cells (4), leading to the generation of further DAMPs (5), thus amplifying the inflammatory response. Activated neutrophils up-regulate the RAGE ligand Mac-1/CD11b on their surface and might therefore interact with airway epithelial cells via a RAGE-dependent mechanism (6). Neutrophil-derived proteases degrade soluble RAGE (7), the endogenous inhibitor of RAGE signalling (8), leading to unopposed neutrophil recruitment, activation and persistence in the airways and a failure to resolve the inflammatory response.
    Figure Legend Snippet: Proposed schematic of the relationship between soluble RAGE and neutrophilic inflammation in chronic airways disease. Epithelial damage (1) caused by environmental insults induces the release of DAMPs (e.g. the RAGE ligands HMGB1, SAA) (2). DAMPs induce recruitment and activation of neutrophils in the airway space (3). DAMPs might also act in an autocrine manner to activate RAGE on airway epithelial cells (4), leading to the generation of further DAMPs (5), thus amplifying the inflammatory response. Activated neutrophils up-regulate the RAGE ligand Mac-1/CD11b on their surface and might therefore interact with airway epithelial cells via a RAGE-dependent mechanism (6). Neutrophil-derived proteases degrade soluble RAGE (7), the endogenous inhibitor of RAGE signalling (8), leading to unopposed neutrophil recruitment, activation and persistence in the airways and a failure to resolve the inflammatory response.

    Techniques Used: Activation Assay, Derivative Assay



    Similar Products

    large molecule rage inhibitor ttp4000  (TransTech Pharma)
    90
    TransTech Pharma large molecule rage inhibitor ttp4000
    Proposed schematic of the relationship between soluble <t>RAGE</t> and neutrophilic inflammation in chronic airways disease. Epithelial damage (1) caused by environmental insults induces the release of DAMPs (e.g. the RAGE ligands HMGB1, SAA) (2). DAMPs induce recruitment and activation of neutrophils in the airway space (3). DAMPs might also act in an autocrine manner to activate RAGE on airway epithelial cells (4), leading to the generation of further DAMPs (5), thus amplifying the inflammatory response. Activated neutrophils up-regulate the RAGE ligand Mac-1/CD11b on their surface and might therefore interact with airway epithelial cells via a RAGE-dependent mechanism (6). Neutrophil-derived proteases degrade soluble RAGE (7), the <t>endogenous</t> <t>inhibitor</t> of RAGE signalling (8), leading to unopposed neutrophil recruitment, activation and persistence in the airways and a failure to resolve the inflammatory response.
    Large Molecule Rage Inhibitor Ttp4000, supplied by TransTech Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/large molecule rage inhibitor ttp4000/product/TransTech Pharma
    Average 90 stars, based on 1 article reviews
    large molecule rage inhibitor ttp4000 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Proposed schematic of the relationship between soluble RAGE and neutrophilic inflammation in chronic airways disease. Epithelial damage (1) caused by environmental insults induces the release of DAMPs (e.g. the RAGE ligands HMGB1, SAA) (2). DAMPs induce recruitment and activation of neutrophils in the airway space (3). DAMPs might also act in an autocrine manner to activate RAGE on airway epithelial cells (4), leading to the generation of further DAMPs (5), thus amplifying the inflammatory response. Activated neutrophils up-regulate the RAGE ligand Mac-1/CD11b on their surface and might therefore interact with airway epithelial cells via a RAGE-dependent mechanism (6). Neutrophil-derived proteases degrade soluble RAGE (7), the endogenous inhibitor of RAGE signalling (8), leading to unopposed neutrophil recruitment, activation and persistence in the airways and a failure to resolve the inflammatory response.

    Journal: British Journal of Pharmacology

    Article Title: RAGE: a new frontier in chronic airways disease

    doi: 10.1111/j.1476-5381.2012.01984.x

    Figure Lengend Snippet: Proposed schematic of the relationship between soluble RAGE and neutrophilic inflammation in chronic airways disease. Epithelial damage (1) caused by environmental insults induces the release of DAMPs (e.g. the RAGE ligands HMGB1, SAA) (2). DAMPs induce recruitment and activation of neutrophils in the airway space (3). DAMPs might also act in an autocrine manner to activate RAGE on airway epithelial cells (4), leading to the generation of further DAMPs (5), thus amplifying the inflammatory response. Activated neutrophils up-regulate the RAGE ligand Mac-1/CD11b on their surface and might therefore interact with airway epithelial cells via a RAGE-dependent mechanism (6). Neutrophil-derived proteases degrade soluble RAGE (7), the endogenous inhibitor of RAGE signalling (8), leading to unopposed neutrophil recruitment, activation and persistence in the airways and a failure to resolve the inflammatory response.

    Article Snippet: Nevertheless, another large molecule RAGE inhibitor (TTP4000), which is a fusion between the ligand binding domains of RAGE and IgG, is still under clinical development and is entering a clinical study in Alzheimer's patients (Transtech Pharma Inc).

    Techniques: Activation Assay, Derivative Assay